Tumor–neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression
Open Access
- 7 May 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (20)
Abstract
The immune landscape of bladder cancer progression is not fully understood, and effective therapies are lacking in advanced bladder cancer. Here, we visualized that bladder cancer cells recruited neutrophils by secreting interleukin-8 (IL-8); in turn, neutrophils played dual functions in bladder cancer, including hepatocyte growth factor (HGF) release and CCL3highPD-L1highsuper-immunosuppressive subset formation. Mechanistically, c-Fos was identified as the mediator of HGF up-regulating IL-8 transcription in bladder cancer cells, which was central to the positive feedback of neutrophil recruitment. Clinically, compared with serum IL-8, urine IL-8 was a better biomarker for bladder cancer prognosis and clinical benefit of immune checkpoint blockade (ICB). Additionally, targeting neutrophils or hepatocyte growth factor receptor (MET) signaling combined with ICB inhibited bladder cancer progression and boosted the antitumor effect of CD8+T cells in mice. These findings reveal the mechanism by which tumor–neutrophil cross talk orchestrates the bladder cancer microenvironment and provide combination strategies, which may have broad impacts on patients suffering from malignancies enriched with neutrophils.Keywords
Funding Information
- MOST | National Natural Science Foundation of China (81670687)
- MOST | National Natural Science Foundation of China (81970661)
- MOST | National Natural Science Foundation of China (81800672)
- Tai Shan Scholar Foundation (ts201511092)
- Primary Research and Development Plan of Shandong Province (2019GSF108123)
- Beijing Xisike Clinical Oncology Research Foundation (Y-2019AZQN-0557)
- MOST | National Natural Science Foundation of China (82303171)
This publication has 57 references indexed in Scilit:
- Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for gliomaCancer Cell, 2023
- Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLRCancer Immunology, Immunotherapy, 2021
- Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesisCell, 2021
- Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsCancer Cell, 2021
- Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formationCancer Cell, 2021
- Bladder CancerJAMA, 2020
- CCL3 Signaling in the Tumor Microenvironment2020
- Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human TumorsCell, 2019
- T Cell Dysfunction in CancerCancer Cell, 2018
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009